Temozolomide: Revision history

From Glioblastoma Treatments
Jump to navigationJump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

8 March 2025

  • curprev 20:5220:52, 8 March 2025‎ Lazy talk contribs‎ 2,933 bytes +19‎ No edit summary
  • curprev 20:5120:51, 8 March 2025‎ Lazy talk contribs‎ 2,914 bytes +2,914‎ Created page with "|drug_name=Temozolomide (TMZ) |FDA_approval=Yes |used_for=Glioblastoma Multiforme (GBM) |clinical_trial_phase=Approved; ongoing trials exploring new combinations |common_side_effects=Nausea, vomiting, constipation, loss of appetite, fatigue, headache, hair loss, low blood cell counts |OS_with=Median survival of 14.6 months; 2-year survival rate approximately 27% |usefulness_rating=4 |usefulness_explanation=Temozolomide is the standard chemotherapy for GBM and has been sh..." Tag: Visual edit: Switched
Retrieved from "http://glioblastomatreatments.wiki:80/index.php?title=Temozolomide"